ArticleScientific reports2025

In silico identification of bilobetin and ginsenoside as dual CK2 and ULK2 inhibitors targeting triple-negative breast cancer.

Md Abid Hossain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.